Knowledge centre

Filter by

Recent posts

TOPRA – Navigating the regulatory challenges of plasmid DNA and synthetic DNA as starting materials for mRNA vaccines
TOPRA – Navigating the regulatory challenges of plasmid DNA and synthetic DNA as starting materials for mRNA vaccines
Read Article
Drug Delivery Today – dbDNA™ an advanced platform for genetic medicines
Drug Delivery Today – dbDNA™ an advanced platform for genetic medicines
Read Article
Webinar – Overcoming Plasmid DNA Limitations in Advanced Therapy Manufacturing
Webinar – Overcoming Plasmid DNA Limitations in Advanced Therapy Manufacturing
Read Article
Molecular Therapy – Safe and stable generation of induced pluripotent stem cells using doggybone DNA vectors
Molecular Therapy – Safe and stable generation of induced pluripotent stem cells using doggybone DNA vectors
Read Article
DNA Vaccines: The Next Stage in the Vaccine Revolution?
DNA Vaccines: The Next Stage in the Vaccine Revolution?
Read more
Nature Biopharma Dealmakers: Reshaping the production of DNA-based therapies
Nature Biopharma Dealmakers: Reshaping the production of DNA-based therapies
Read more
Global Business Reports: Intro to US Life Sciences
Global Business Reports: Intro to US Life Sciences
Read more
SynBioBeta: The DNA Industry Is Going Cell-Free
SynBioBeta: The DNA Industry Is Going Cell-Free
Read more
The Telegraph: UK’s Touchlight to step up DNA production after fundraising
The Telegraph: UK’s Touchlight to step up DNA production after fundraising
Read more
SynBioBeta: Living Power: This Bio-Battery Is Harnessing the Power of DNA
SynBioBeta: Living Power: This Bio-Battery Is Harnessing the Power of DNA
Read more
BioProcess International: With $58m in hand, Touchlight looks to triple DNA manufacturing capacity
BioProcess International: With $58m in hand, Touchlight looks to triple DNA manufacturing capacity
Read more
Endpoints News: Synthetic DNA player Touchlight scores $60M round to more than triple manufacturing capacity as mRNA gets hot
Endpoints News: Synthetic DNA player Touchlight scores $60M round to more than triple manufacturing capacity as mRNA gets hot
Read more